38 related articles for article (PubMed ID: 6381384)
1. History and Development of Autologous Stem Cell Transplantation for Acute Myeloid Leukemia.
Gorin NC
Clin Hematol Int; 2021 Sep; 3(3):83-95. PubMed ID: 34820613
[TBL] [Abstract][Full Text] [Related]
2. Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysine.
Bruntsch U; Groos G; Hiller TA; Wandt H; Tigges FJ; Gallmeier WM
Invest New Drugs; 1985; 3(3):293-6. PubMed ID: 4066222
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow purging with mafosfamide--a critical survey.
Sindermann H; Peukert M; Hilgard P
Blut; 1989 Nov; 59(5):432-41. PubMed ID: 2684298
[TBL] [Abstract][Full Text] [Related]
4. The potential role of amifostine (Ethyol) in haematological malignancies.
Gorin NC
Eur J Cancer; 1996; 32A Suppl 4():S31-9. PubMed ID: 8976820
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide). First clinical results.
Hervé P; Cahn JY; Plouvier E; Flesch M; Tamayo E; Leconte des Floris R; Peters A
Invest New Drugs; 1984; 2(2):245-52. PubMed ID: 6381384
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia.
Gorin NC; Douay L; Laporte JP; Lopez M; Mary JY; Najman A; Salmon C; Aegerter P; Stachowiak J; David R
Blood; 1986 May; 67(5):1367-76. PubMed ID: 3516254
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of ASTA Z 7557 (INN mafosfamide) to normal- and leukemic stem cells: implications for autologous bone marrow transplantation.
Hagenbeek A; Martens AC
Invest New Drugs; 1984; 2(2):237-43. PubMed ID: 6381383
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
9. ASTA Z 7557 (INN mafosfamide) for the in vitro treatment of human leukemic bone marrows.
Douay L; Gorin NC; Laporte JP; Lopez M; Najman A; Duhamel G
Invest New Drugs; 1984; 2(2):187-90. PubMed ID: 6381382
[TBL] [Abstract][Full Text] [Related]
10. In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213).
Deconinck E; Tamayo E; Hervé P
Bone Marrow Transplant; 1990 Jan; 5(1):13-8. PubMed ID: 2297586
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of cyclophosphamide and metabolites.
Colvin M; Hilton J
Cancer Treat Rep; 1981; 65 Suppl 3():89-95. PubMed ID: 7049370
[No Abstract] [Full Text] [Related]
12. Autologous marrow transplantation in cancer therapy.
Herzig GP
Prog Hematol; 1981; 12():1-23. PubMed ID: 7041172
[No Abstract] [Full Text] [Related]
13. Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide.
Sharkis SJ; Santos GW; Colvin M
Blood; 1980 Mar; 55(3):521-3. PubMed ID: 6986920
[TBL] [Abstract][Full Text] [Related]
14. Long-term culture of human bone marrow cells.
Gartner S; Kaplan HS
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4756-9. PubMed ID: 6933522
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]